Free Trial
→ URGENT: This Altcoin Opportunity Won’t Wait – Act Now (From Crypto Swap Profits) (Ad)

10 Best Small Cap Stocks to Buy Now - 5 of 10

Slide 5
Back to 4
Continue to 6
 
Back to 4
Continue to 6
 

OnKure Therapeutics (NASDAQ:OKUR)

Consensus Rating
Buy
Rating Score
3.4
Ratings Breakdown
5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$36.00 (341.7% Upside)

About OnKure Therapeutics

OnKure Therapeutics logoReneo Pharmaceuticals Incis a clinical stage pharmaceutical company. It is focused on the development and commercialization of therapies for patients with rare, genetic, mitochondrial diseases. Reneo Pharmaceuticals Incis based in SAN DIEGO.
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
12/5/2024Leerink PartnrsUpgradeStrong-Buy
12/5/2024Leerink PartnersInitiated CoverageOutperform$33.00
11/8/2024HC WainwrightReiterated RatingBuy ➝ Buy$40.00 ➝ $40.00
10/17/2024HC WainwrightReiterated RatingBuy$40.00
10/10/2024Lifesci CapitalUpgradeStrong-Buy
10/10/2024OppenheimerInitiated CoverageOutperform$35.00
Slide 5
Back to 4
Continue to 6
 

If you see ONE chart today… make it this one (Ad)

$1 Trillion… That’s how much Big Tech is set to spend on AI investment in the coming months—according to Goldman Sachs. This investment is driving an A.I. boom that’s being felt across many industries… Including a specific group of energy tickers since A.I. data centers use a massive amount of power. One of those tickers is CEG, up nearly 600% in the last 3 years… Combined with the upcoming presidential election, we have the recipe for a major shakeup in the market. You see, each time the U.S. elects a new president, one overlooked part of the energy sector tends to see a big move. Fact is… this energy niche is BOOMING.

And expects this underappreciated niche to continue rallying well into 2026.

More From MarketBeat
Amazon coin set to soar 25X – starting December 16th?
This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...
True Market Insiders | Sponsored
7 Stocks That Hold Appeal for Aggressive Investors
In times of market volatility, many investors sell stocks as part of a flight to safety. There's logic to this...
MarketBeat
Did You See Trump’s Bombshell Exec. Order 001?
Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."
Banyan Hill Publishing | Sponsored
7 Consumer Discretionary Stocks That Will Continue to Rally
Consumer discretionary stocks appear to be among the winners from the ongoing Trump trade following the U.S. p...
MarketBeat
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
7 Chip Stocks to Buy on the Dip
For much of the industrial era, semiconductors (i.e. chips) were a cyclical sector. For investors, that meant ...
MarketBeat